2025 Q4 -tulosraportti
9 päivää sitten
‧1 t 1 min
7,95 DKK/osake
Irtoamispäivä 27.3.
3,80%Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
2 106 621
Myynti
Määrä
2 063 762
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 320 | - | - | ||
| 10 | - | - | ||
| 425 | - | - | ||
| 1 550 | - | - | ||
| 400 | - | - |
Ylin
314,85VWAP
Alin
308,5VaihtoMäärä
1 729,1 5 552 349
VWAP
Ylin
314,85Alin
308,5VaihtoMäärä
1 729,1 5 552 349
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 5.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 7.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·3 min sittenOn Monday, we open at +5%. After this, it will slowly trickle back to the start.
·2 t sittenhttps://njbiz.com/hims-hers-halts-glp-1-pill-novo-nordisk-lawsuit/ Partially translated from this link: FDA's concerns The U.S. Food and Drug Administration has also stated that it will take action against Hims & Hers. In a press release from February 6, the agency announced that it plans to impose restrictions on GLP-1 ingredients used in unapproved compounded drugs that companies like Hims & Hers have marketed as approved treatments. FDA cited concerns regarding quality, safety, and potential violations of federal law. FDA Commissioner Marty Makary promised "swift action against companies that mass-produce illegal copycat products and claim they are identical to FDA-approved products." "FDA cannot verify the quality, safety, or effectiveness of unapproved drugs," he wrote in a social media post. FDA cannot verify the quality, safety, or effectiveness of unapproved drugs. – Marty Makary, FDA Commissioner I have seen elsewhere that FDA is considering shutting down a supplier in China I believe that it is different this time because Trump's interests are threatened I believe it is more than words We will see I saw this: marco rubio interview These are truly new tones
·3 t sittenThis article quotes statements from Novo Nordisk’s CEO that the company aims to reach approx. 15 million new patients when Medicare starts covering obesity medication, and discusses expectations for market potential and coverage of treatments. 👉 Read the article: https://www.benzinga.com/news/health-care/26/02/50567757/novo-nordisk-ceo-sees-opportunity-for-15-million-new-patients-as-medicare-covers-obesity-drugs
·4 t sitten · MuokattuRegarding Hims @ Hers, all links concerning weight loss are deactivated. This can probably only be seen as a sign that they expect FDA action not only concerns the pill, but also the injection. What do you think? Good evening.
·3 t sittenI think the FDA finally does its job and that NN can adjust the guidance at the next quarterly report. If the 7.2 mg dose is approved soon, then, Novo Nordisk will enter the summer with the strongest product portfolio they have ever had. No longer in a defensive position, but on the attack with strong pill numbers.
·6 t sittenOn weekdays, we have many deep serious talks about Novo. Now it's the weekend and time for some fun: A duck walks into a bar. Duck: Do you have shares? Bartender: No! Duck: Do you have shares? Bartender: No, I just told you! Duck: Do you have shares? Bartender: No, for crying out loud. We have NO shares!!! Duck: Do you have shares? Bartender: No, for hell's sake, and if you ask again I'll nail your beak to the counter. Duck: Do you have nails? Bartender: No! Duck: Do you have shares?.........
·3 t sittenWas just in Rema to get my daily ration of smokes and cheap beer😋 There I met a nun whose bike had a flat tire. Kind as I am - I patched it for her😇 She got so happy she threw herself down and pulled off her pants😳 Take what you want!! She said😳 I took the bike - couldn't fit her pants and had lost a lot on Novo shares😏
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
9 päivää sitten
‧1 t 1 min
7,95 DKK/osake
Irtoamispäivä 27.3.
3,80%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 min sittenOn Monday, we open at +5%. After this, it will slowly trickle back to the start.
- ·2 t sittenhttps://njbiz.com/hims-hers-halts-glp-1-pill-novo-nordisk-lawsuit/ Partially translated from this link: FDA's concerns The U.S. Food and Drug Administration has also stated that it will take action against Hims & Hers. In a press release from February 6, the agency announced that it plans to impose restrictions on GLP-1 ingredients used in unapproved compounded drugs that companies like Hims & Hers have marketed as approved treatments. FDA cited concerns regarding quality, safety, and potential violations of federal law. FDA Commissioner Marty Makary promised "swift action against companies that mass-produce illegal copycat products and claim they are identical to FDA-approved products." "FDA cannot verify the quality, safety, or effectiveness of unapproved drugs," he wrote in a social media post. FDA cannot verify the quality, safety, or effectiveness of unapproved drugs. – Marty Makary, FDA Commissioner I have seen elsewhere that FDA is considering shutting down a supplier in China I believe that it is different this time because Trump's interests are threatened I believe it is more than words We will see I saw this: marco rubio interview These are truly new tones
- ·3 t sittenThis article quotes statements from Novo Nordisk’s CEO that the company aims to reach approx. 15 million new patients when Medicare starts covering obesity medication, and discusses expectations for market potential and coverage of treatments. 👉 Read the article: https://www.benzinga.com/news/health-care/26/02/50567757/novo-nordisk-ceo-sees-opportunity-for-15-million-new-patients-as-medicare-covers-obesity-drugs
- ·4 t sitten · MuokattuRegarding Hims @ Hers, all links concerning weight loss are deactivated. This can probably only be seen as a sign that they expect FDA action not only concerns the pill, but also the injection. What do you think? Good evening.·3 t sittenI think the FDA finally does its job and that NN can adjust the guidance at the next quarterly report. If the 7.2 mg dose is approved soon, then, Novo Nordisk will enter the summer with the strongest product portfolio they have ever had. No longer in a defensive position, but on the attack with strong pill numbers.
- ·6 t sittenOn weekdays, we have many deep serious talks about Novo. Now it's the weekend and time for some fun: A duck walks into a bar. Duck: Do you have shares? Bartender: No! Duck: Do you have shares? Bartender: No, I just told you! Duck: Do you have shares? Bartender: No, for crying out loud. We have NO shares!!! Duck: Do you have shares? Bartender: No, for hell's sake, and if you ask again I'll nail your beak to the counter. Duck: Do you have nails? Bartender: No! Duck: Do you have shares?.........·3 t sittenWas just in Rema to get my daily ration of smokes and cheap beer😋 There I met a nun whose bike had a flat tire. Kind as I am - I patched it for her😇 She got so happy she threw herself down and pulled off her pants😳 Take what you want!! She said😳 I took the bike - couldn't fit her pants and had lost a lot on Novo shares😏
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
2 106 621
Myynti
Määrä
2 063 762
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 320 | - | - | ||
| 10 | - | - | ||
| 425 | - | - | ||
| 1 550 | - | - | ||
| 400 | - | - |
Ylin
314,85VWAP
Alin
308,5VaihtoMäärä
1 729,1 5 552 349
VWAP
Ylin
314,85Alin
308,5VaihtoMäärä
1 729,1 5 552 349
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 5.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 7.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2025 Q4 -tulosraportti
9 päivää sitten
‧1 t 1 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 5.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 7.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
7,95 DKK/osake
Irtoamispäivä 27.3.
3,80%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 min sittenOn Monday, we open at +5%. After this, it will slowly trickle back to the start.
- ·2 t sittenhttps://njbiz.com/hims-hers-halts-glp-1-pill-novo-nordisk-lawsuit/ Partially translated from this link: FDA's concerns The U.S. Food and Drug Administration has also stated that it will take action against Hims & Hers. In a press release from February 6, the agency announced that it plans to impose restrictions on GLP-1 ingredients used in unapproved compounded drugs that companies like Hims & Hers have marketed as approved treatments. FDA cited concerns regarding quality, safety, and potential violations of federal law. FDA Commissioner Marty Makary promised "swift action against companies that mass-produce illegal copycat products and claim they are identical to FDA-approved products." "FDA cannot verify the quality, safety, or effectiveness of unapproved drugs," he wrote in a social media post. FDA cannot verify the quality, safety, or effectiveness of unapproved drugs. – Marty Makary, FDA Commissioner I have seen elsewhere that FDA is considering shutting down a supplier in China I believe that it is different this time because Trump's interests are threatened I believe it is more than words We will see I saw this: marco rubio interview These are truly new tones
- ·3 t sittenThis article quotes statements from Novo Nordisk’s CEO that the company aims to reach approx. 15 million new patients when Medicare starts covering obesity medication, and discusses expectations for market potential and coverage of treatments. 👉 Read the article: https://www.benzinga.com/news/health-care/26/02/50567757/novo-nordisk-ceo-sees-opportunity-for-15-million-new-patients-as-medicare-covers-obesity-drugs
- ·4 t sitten · MuokattuRegarding Hims @ Hers, all links concerning weight loss are deactivated. This can probably only be seen as a sign that they expect FDA action not only concerns the pill, but also the injection. What do you think? Good evening.·3 t sittenI think the FDA finally does its job and that NN can adjust the guidance at the next quarterly report. If the 7.2 mg dose is approved soon, then, Novo Nordisk will enter the summer with the strongest product portfolio they have ever had. No longer in a defensive position, but on the attack with strong pill numbers.
- ·6 t sittenOn weekdays, we have many deep serious talks about Novo. Now it's the weekend and time for some fun: A duck walks into a bar. Duck: Do you have shares? Bartender: No! Duck: Do you have shares? Bartender: No, I just told you! Duck: Do you have shares? Bartender: No, for crying out loud. We have NO shares!!! Duck: Do you have shares? Bartender: No, for hell's sake, and if you ask again I'll nail your beak to the counter. Duck: Do you have nails? Bartender: No! Duck: Do you have shares?.........·3 t sittenWas just in Rema to get my daily ration of smokes and cheap beer😋 There I met a nun whose bike had a flat tire. Kind as I am - I patched it for her😇 She got so happy she threw herself down and pulled off her pants😳 Take what you want!! She said😳 I took the bike - couldn't fit her pants and had lost a lot on Novo shares😏
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
2 106 621
Myynti
Määrä
2 063 762
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 320 | - | - | ||
| 10 | - | - | ||
| 425 | - | - | ||
| 1 550 | - | - | ||
| 400 | - | - |
Ylin
314,85VWAP
Alin
308,5VaihtoMäärä
1 729,1 5 552 349
VWAP
Ylin
314,85Alin
308,5VaihtoMäärä
1 729,1 5 552 349
Välittäjätilasto
Dataa ei löytynyt